Yoshida Yu, Izumi Ririko, Iwashita Saki, Nakashima Natsumi, Kishida Kaori, Imachi Yuzo, Shimada Yukiyo, Maehara Kana, Wada Tomoko, Ando Mariko, Hamasaki Yoichiro, Kurihara Shuichi, Onjo Sachiko, Nishida Makoto
Department of Obstetrics and Gynecology, Japanese Red Cross Fukuoka Hospital, 3-1-1 Ohgusu, Minami-ku, Fukuoka 815-8555, Japan.
Gynecol Oncol Rep. 2020 Nov 21;34:100676. doi: 10.1016/j.gore.2020.100676. eCollection 2020 Nov.
Post-transplant lymphoproliferative disorder (PTLD) refers to a group of diseases, characterized by abnormal proliferation of lymphocytes, that develop after organ transplantation. PTLD is associated with poor prognosis, and has become a major problem for transplant patients. In this report, we described a case of malignant lymphoma of the cervix in a bicollis uterus considered to be a PTLD in a patient after renal transplantation. The incidence of this disease is expected to increase as the survival rate of transplant patients improves. Hence, it is very important for gynecological oncologists to consider the presence of PTLD when examining such patients.
移植后淋巴细胞增生性疾病（PTLD）是指一组在器官移植后发生的、以淋巴细胞异常增殖为特征的疾病。PTLD预后较差，已成为移植患者面临的一个主要问题。在本报告中，我们描述了一例肾移植术后患者发生在双子宫宫颈的恶性淋巴瘤，该淋巴瘤被认为是PTLD。随着移植患者生存率的提高，预计这种疾病的发病率将会增加。因此，妇科肿瘤学家在检查此类患者时考虑PTLD的存在非常重要。
